AffOrg.i
Exploration
Accueil
Racine
Exploration
Accueil
Racine

Serveur d'exploration sur la maladie de Parkinson - Exploration (Accueil)

Index « AffOrg.i » - entrée « Université de Turku »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Université de Toulouse < Université de Turku < Université de Twente  Facettes :

List of bibliographic references indexed by Université de Turku

Number of relevant bibliographic references: 42.
[0-20] [0 - 20][0 - 42][20-40]
Ident.Authors (with country if any)Title
000128 (2011) M. S. Lee [Corée du Sud] ; C. H. Lyoo [Corée du Sud] ; Y. H. Ryu [Corée du Sud] ; H. S. Lim [Corée du Sud] ; C. M. Nam [Corée du Sud] ; H. S. Kim [Corée du Sud] ; J. O. Rinne [Finlande]The effect of age on motor deficits and cerebral glucose metabolism of Parkinson’s disease
000722 (2010) M. Soilu-H Nninen ; E. Broberg ; M. Röytt ; P. Mattila ; J. Rinne [Finlande] ; V. Hukkanen [Finlande]Expression of LIF and LIF receptor beta in Alzheimer’s and Parkinson’s diseases
000B79 (2009) Anna Brück [Finlande] ; Sargo Aalto [Finlande] ; Elina Rauhala [Finlande] ; Jörgen Bergman [Finlande] ; Reijo Marttila [Finlande] ; Juha O. Rinne [Finlande]A follow‐up study on 6‐[18F]fluoro‐L‐dopa uptake in early Parkinson's disease shows nonlinear progression in the putamen
000D88 (2008) Aki S. Havulinna [Finlande] ; Pentti J. Tienari [Finlande] ; Reijo J. Marttila [Finlande] ; Kirsti K. Martikainen [Finlande] ; Johan G. Eriksson [Finlande] ; Olli Taskinen [Finlande] ; Elena Moltchanova [Finlande] ; Marjatta Karvonen [Finlande]Geographical variation of medicated parkinsonism in Finland during 1995 to 2000
001074 (2007) Chul Hyoung Lyoo [Corée du Sud] ; Sargo Aalto [Finlande] ; Juha O. Rinne [Finlande] ; Ki Ook Lee [Corée du Sud] ; Seung Hun Oh [Corée du Sud] ; Jin Woo Chang [Corée du Sud] ; Myung Sik Lee [Corée du Sud]Different cerebral cortical areas influence the effect of subthalamic nucleus stimulation on parkinsonian motor deficits and freezing of gait
001241 (2006) Kirsti K. Martikainen [Finlande] ; Tiina H. Luukkaala [Finlande] ; Reijo J. Marttila [Finlande]Parkinson's disease and working capacity
001720 (2003) Elina Nurmi [Finlande] ; Jörgen Bergman [Finlande] ; Olli Eskola [Finlande] ; Olof Solin [Finlande] ; Tero Vahlberg [Finlande] ; Pirkko Sonninen [Finlande] ; Juha O. Rinne [Finlande]Progression of dopaminergic hypofunction in striatal subregions in Parkinson's disease using [18F]CFT PET
001758 (2003) N. Kemppainen [Finlande] ; M. Laine [Finlande] ; M. P. Laakso [Finlande] ; V. Kaasinen [Finlande] ; K. N Gren [Finlande] ; T. Vahlberg [Finlande] ; T. Kurki [Finlande] ; J. O. Rinne [Finlande]Hippocampal dopamine D2 receptors correlate with memory functions in Alzheimer's disease
001990 (2001) Juha O. Rinne [Finlande] ; Elina Nurmi [Finlande] ; Hanna M. Ruottinen [Finlande] ; Jörgen Bergman [Finlande] ; Olli Eskola [Finlande] ; Olof Solin [Finlande][18F]FDOPA and [18F]CFT are both sensitive PET markers to detect presynaptic dopaminergic hypofunction in early Parkinson's disease
001A22 (2001) Elina Nurmi [Finlande] ; Hanna M. Ruottinen [Finlande] ; Jörgen Bergman [Finlande] ; Merja Haaparanta [Finlande] ; Olof Solin [Finlande] ; Pirkko Sonninen [Finlande] ; Juha O. Rinne [Finlande]Rate of progression in Parkinson's disease: A 6‐[18F]fluoro‐L‐dopa PET study
001A31 (2001) Anna Brück [Finlande] ; Raija Portin [Finlande] ; Arja Lindell [Finlande] ; Arto Laihinen [Finlande] ; Jörgen Bergman [Finlande] ; Merja Haaparanta [Finlande] ; Olof Solin [Finlande] ; Juha O. Rinne [Finlande]Positron emission tomography shows that impaired frontal lobe functioning in Parkinson’s disease is related to dopaminergic hypofunction in the caudate nucleus
001A85 (2001) Hanna M. Ruottinen [Finlande] ; Mikko Niinivirta [Finlande] ; Jörgen Bergman [Finlande] ; Vesa Oikonen [Finlande] ; Olof Solin [Finlande] ; Olli Eskola [Finlande] ; Esa Eronen [Finlande] ; Pirkko Sonninen [Finlande] ; Urpo K. Rinne [Finlande]Detection of response to COMT inhibition in FDOPA PET in advanced Parkinson's disease requires prolonged imaging
001C61 (2000) Oleg V. Anichtchik [Finlande] ; Juha O. Rinne [Finlande] ; Hannu Kalimo [Finlande] ; Pertti Panula [Finlande]An Altered Histaminergic Innervation of the Substantia Nigra in Parkinson's Disease
001D39 (1999) H. Przuntek ; B. Conrad [Allemagne] ; J. Dichgans ; P. H. Kraus ; P. Krauseneck ; G. Pergande ; U. Rinne [Finlande] ; K. Schimrigk ; J. Schnitker ; H. P. Vogel [Allemagne]SELEDO: a 5‐y‐ear long‐term trial on the effect of selegiline in early parkinsonian patients treated with levodopa
001D92 (1999) Anne-Maria Kuopio [Finlande] ; Reijo J. Marttila [Finlande] ; Hans Helenius [Finlande] ; Urpo K. Rinne [Finlande]Environmental risk factors in Parkinson's disease
001F63 (1997) Shuang Yong Ma [Finlande] ; Matias Röytt [Finlande] ; Juha O. Rinne [Finlande] ; Yrjö Collan [Finlande] ; Urpo K. Rinne [Finlande]Correlation between neuromorphometry in the substantia nigra and clinical features in Parkinson's disease using disector counts
002115 (1996) Shuang Yong Ma [Finlande] ; Juha O. Rinne [Finlande] ; Yrjö Collan [Finlande] ; Matias Röytt [Finlande] ; Urpo K. Rinne [Finlande]A quantitative morphometrical study of neuron degeneration in the substantia nigra in Parkinson's disease
002224 (1995) Juha O. Rinne [Finlande] ; Jyrki T. Kuikka [Finlande] ; Kim A. Bergström [Finlande] ; Urpo K. Rinne [Finlande]Striatal dopamine transporter in different disability stages of Parkinson's disease studied with [123I]β-CIT SPECT
002247 (1995) Juha O. Rinne [Finlande] ; Arto Laihinen [Finlande] ; Hanna Ruottinen [Finlande] ; Ulla Ruotsalainen [Finlande] ; Kjell N Gren [Finlande] ; Pertti Lehikoinen [Finlande] ; Vesa Oikonen [Finlande] ; U. K. Rinne [Finlande]Increased density of dopamine D2 receptors in the putamen, but not in the caudate nucleus in early Parkinson's disease: a PET study with [11C]raclopride
002528 (1993) Rinne [Finlande]Nigral degeneration in parkinson's disease
002549 (1993) H. Heinonen [Finlande] ; M. Savij Rvi [Finlande] ; M. Kotila [Finlande] ; A. Hajba [Finlande] ; M. Scheinin [Finlande]Effects of monoamine oxidase inhibition by selegiline on concentrations of noradrenaline and monoamine metabolites in CSF of patients with Alzheimer's disease

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AffOrg.i -k "Université de Turku" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AffOrg.i  \
                -Sk "Université de Turku" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AffOrg.i
   |clé=    Université de Turku
}}
Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024